Geode Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Sell |
|
|||||
|
2025
Q1 | $1.7M | Buy |
|
|||||
|
2024
Q4 | $2.6M | Sell |
|
|||||
|
2024
Q3 | $5.53M | Buy |
|
|||||
|
2024
Q2 | $5.46M | Buy |
|
|||||
|
2024
Q1 | $5.73M | Buy |
|
|||||
|
2023
Q4 | $3.59M | Buy |
|
|||||
|
2023
Q3 | $2.32M | Buy |
|
|||||
|
2023
Q2 | $4.21M | Buy |
|
|||||
|
2023
Q1 | $4.19M | Buy |
|
|||||
|
2022
Q4 | $3.07M | Buy |
|
|||||
|
2022
Q3 | $3.77M | Buy |
|
|||||
|
2022
Q2 | $2.5M | Buy |
|
|||||
|
2022
Q1 | $2.63M | Buy |
|
|||||
|
2021
Q4 | $4.72M | Buy |
|
|||||
|
2021
Q3 | $5.74M | Sell |
|
|||||
|
2021
Q2 | $5.88M | Buy |
|
|||||
|
2021
Q1 | $6.33M | Buy |
|
|||||
|
2020
Q4 | $2.63M | Sell |
|
|||||
|
2020
Q3 | $1.11M | Sell |
|
|||||
|
2020
Q2 | $1.63M | Buy |
|
|||||
|
2020
Q1 | $1.34M | Buy |
|
|||||
|
2019
Q4 | $2.78M | Sell |
|
|||||
|
2019
Q3 | $2.02M | Buy |
|
|||||
|
2019
Q2 | $4.11M | Buy |
|
|||||
|
2019
Q1 | $3.46M | Buy |
|
|||||
|
2018
Q4 | $3.75M | Buy |
|
|||||
|
2018
Q3 | $5.88M | Buy |
|
|||||
|
2018
Q2 | $6.34M | Buy |
|
|||||
|
2018
Q1 | $3.87M | Buy |
|
|||||
|
2017
Q4 | $4.38M | Buy |
|
|||||
|
2017
Q3 | $5.32M | Buy |
|
|||||
|
2017
Q2 | $6.96M | Sell |
|
|||||
|
2017
Q1 | $6.21M | Buy |
|
|||||
|
2016
Q4 | $5.94M | Buy |
|
|||||
|
2016
Q3 | $7.39M | Sell |
|
|||||
|
2016
Q2 | $5.97M | Buy |
|
|||||
|
2016
Q1 | $4.22K | Buy |
|
|||||
|
2015
Q4 | $4.25M | Buy |
|
|||||
|
2015
Q3 | $3.25M | Buy |
|
|||||
|
2015
Q2 | $2.42M | Buy |
|
|||||
|
2015
Q1 | $1.78M | Buy |
|
|||||
|
2014
Q4 | $1.65M | Buy |
|
|||||
|
2014
Q3 | $2.47M | Buy |
|
|||||
|
2014
Q2 | $2.77M | Buy |
|
|||||
|
2014
Q1 | $2.98M | Buy |
|
|||||
|
2013
Q4 | $3.01M | Buy |
|
|||||
|
2013
Q3 | $3.92M | Sell |
|
|||||
|
2013
Q2 | $4.53M | Buy |
|